RxDoctor Payments Data

Brooke Matthews

Primary Care · Suwanee, GANPI 1093271918

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Melinta Therapeutics, LLC at 31.1% of the total. Reporting peaked in 2021 at $958 and has fallen 54.5% since, to $436 in 2025.

$3,775in general payments, 2019–2025

Across 192 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Melinta Therapeutics, LLC$1K
  • Gilead$385
  • Merck$357
  • La Jolla Pharmaceutical Company$330
  • Paratek Pharmaceuticals, Inc.$276
  • Astellas Pharma US Inc$205
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,58395%
  • Education$1915%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,775 in reported general payments places this provider in the 85th percentile of 235 primary care providers in Georgia.

See all primary care providers in Georgia

Other primary care in Suwanee

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →